Peng Ge
Xi'an, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
M2 macrophage-derived exosomal EHF transcriptionally activates FGFR1 to promote malignant phenotypes and glycolysis in NSCLC.
Journal: Journal of bioenergetics and biomembranes
Published: May 28, 2026
Zeylenone Attenuates Tamoxifen Resistance by Directly Binding to CTCF and Inhibiting the CTCF-CENPK-JAK1/STAT3 Signaling Axis in Breast Cancer.
Journal: Drug development research
Published: November 19, 2025
A Successfully Treated Case of Mycobacterium chelonae Pulmonary Infection and a Literature Review (1990-2025).
Journal: Infection and drug resistance
Published: November 05, 2025
The evolving role of neoadjuvant immunotherapy in resectable non-small cell lung cancer: a narrative review.
Journal: Journal of thoracic disease
Published: October 23, 2025
Physiological and psychological symptom management based on electronic patient-reported outcomes: the TD-WELLBEING randomized clinical trial.
Journal: British journal of cancer
Published: February 28, 2025
The dynamic effects of nutritional status on chemotherapy-related toxicity in patients with non-Hodgkin's lymphoma.
Journal: European journal of clinical nutrition
Published: May 29, 2024
Hsa_circ_0088036 promotes nonsmall cell lung cancer progression by regulating miR-1343-3p/Bcl-3 axis through TGFβ/Smad3/EMT signaling.
Journal: Molecular carcinogenesis
Published: March 23, 2023
Controllable CO2 Reduction or Hydrocarbon Oxidation Driven by Entire Solar via Silver Quantum Dots Direct Photocatalysis.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: November 21, 2022
Application of the patient-reported outcome-based postoperative symptom management model in lung cancer: a multicenter randomized controlled trial protocol.
Journal: Trials
Published: August 17, 2022
LncRNA FOXD3-AS1 promotes breast cancer progression by mediating ARF6.
Journal: Breast cancer (Tokyo, Japan)
Published: October 27, 2021
LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis.
Journal: Experimental and molecular pathology
Published: September 08, 2020
Last Updated: 09/26/2026